“Dupilumab Improves Patient-Reported Outcomes As Early As 1 Month Among Adults With Prurigo Nodularis in Clinical Practice: Initial Results from the RELIEVE-PN Study”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 6, Nov. 2024, p. s506, https://doi.org/10.25251/skin.8.supp.506.